心力衰竭中的电疗法:不断发展的技术和指示
1Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Karolinska Universitetssjukhuset, Stockholm, Sweden.
Presse medicale (Paris, France : 1983)
|October 28, 2023
概括
对心力衰竭的设备治疗已经进步,结合了诸如心脏再同步疗法 (CRT) 和无节奏等新技术. 需要进一步的证据来进行最佳的患者选择和实施,以改善心力衰竭 (HF) 的结果.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 医疗器械技术 医疗器械技术
背景情况:
- 对心力衰竭 (HF) 的设备治疗在过去二十年中取得了重大进展.
- 目前的知识包括扩展的指示,评估和不断发展的设备技术,包括心脏再同步疗法 (CRT),无步调和导电系统步调 (他的捆绑和左捆绑分支区域步调).
研究的目的:
- 审查心力衰竭器械治疗的演变.
- 要突出扩大范围的设备技术及其指示.
- 确定有关新技术和常见征兆的进一步证据的需要,并强调个性化医疗在HF管理中的作用.
主要方法:
- 审查当前文献和临床实践指南关于心力衰竭器械治疗.
- 分析设备技术的进步,包括CRT,无步调和导电系统步调.
- 讨论个性化医学的应用在选择设备植入和移除程序的候选人.
主要成果:
- 对于HF的设备治疗已经发展到包括CRT,无节奏和导电系统节奏.
- 对于较新的技术和某些常见的迹象,如心房动和设备升级,仍然缺乏可靠的证据.
- 个性化医疗对于优化CRT患者选择,初级预防ICD程序以及心脏收缩性调制 (CCM) 等新型设备至关重要.
结论:
- 设备治疗的快速发展为改善心力衰竭结果提供了显著的潜力.
- 解决新技术的证据缺口和通过个性化医疗来完善患者选择是关键的挑战.
- 设备和药物治疗的正确实施对于积极影响HF结果至关重要.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
01:30Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
01:30Heart Failure IV: Classification and Diagnostic Evaluation
18
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:26Heart Failure Drugs: Inotropic Agents
598
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
598
01:30Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85